Real Money January 12, 2022
As M&A investments could hit $400 billion this year, watch for buys in health technology and data, biotech, pharma and medical devices.
The year 2021 went out with a bang for health care M&A action, with major tech companies getting in on the action — but this year should see lots more buys ahead with hundreds of billions of dollars waiting to be spent, according to several experts.
“‘Healthtech’ is a natural target for more consolidation today on the basis that the space exhibits the classic advantages of scale, yet most companies are still-underscaled, such that larger players can bring the broader solution to fruition and achieve the natural scale advantages,” Cody Powers, a partner and principal at management consulting...
Today's Sponsors
Today's Sponsor